2003
DOI: 10.1001/archderm.139.2.136
|View full text |Cite
|
Sign up to set email alerts
|

Successful Treatment of Granulomatous Cheilitis With Thalidomide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2004
2004
2022
2022

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(15 citation statements)
references
References 21 publications
(16 reference statements)
0
15
0
Order By: Relevance
“…Corticosteroids have been used by topical, intralesional (2–3 mg of triamcinolone suspension weekly for 5–8 months), and systemic administration with variable and temporary benefit 5 . Clofazimine, hydroxychloroquine, dapsone, sulphasalazine, thalidomide, danazol and minocycline have also been employed without reproducible benefit 3,5,12,24,28 . Surgery has produced initial improvement in the appearance, but postoperative intralesional steroids are usually required and are often ineffective in preventing relapse 23 .…”
Section: Discussionmentioning
confidence: 99%
“…Corticosteroids have been used by topical, intralesional (2–3 mg of triamcinolone suspension weekly for 5–8 months), and systemic administration with variable and temporary benefit 5 . Clofazimine, hydroxychloroquine, dapsone, sulphasalazine, thalidomide, danazol and minocycline have also been employed without reproducible benefit 3,5,12,24,28 . Surgery has produced initial improvement in the appearance, but postoperative intralesional steroids are usually required and are often ineffective in preventing relapse 23 .…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, in a case report by Thomas et al. , 25 thalidomide was successfully used in a patient with GC in doses of 100 mg daily which were decreased to every other day. Thalidomide also demonstrates TNF‐α inhibitory action, which may explain its effectiveness 25 .…”
Section: Other Immunomodulatorsmentioning
confidence: 93%
“…, 25 thalidomide was successfully used in a patient with GC in doses of 100 mg daily which were decreased to every other day. Thalidomide also demonstrates TNF‐α inhibitory action, which may explain its effectiveness 25 . Although these agents and the targeting of TNF‐α represent a promising avenue for future treatment, their long‐term safety and efficacy remains to be seen in addressing GC.…”
Section: Other Immunomodulatorsmentioning
confidence: 99%
“…611 In a further case the granulomatous cheilitis was regarded as the consequence of a tuberculid. 616,621,622 Triamcinolone injections have also been used, both alone, 623,624 and combined with dapsone. 613 Occasional cases have been associated with other granulomatous skin lesions or granulomatous lymphadenopathy.…”
Section: Melkersson-rosenthal Syndromementioning
confidence: 99%